Loading
Latest filing published 14 Nov 2023 for Tabula Rasa HealthCare, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Thomas Cancro in Tabula Rasa HealthCare, Inc., where the filings describe the role as finance chief. The record holds 7 filings, for trades running from 28 February 2022 to 3 November 2023.
Purchases make up the whole of the open-market record (1 purchase, €47k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.
The latest filing, published on 14 November 2023, reports a transaction in Tabula Rasa HealthCare, Inc. The latest purchase dates back some time: it was published 1,410 days ago, on 14 December 2022. Filings reach the SEC (Form 4) feed a median of 11 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations